ISFIYA, Israel, Aug. 29, 2018 /PRNewswire/ -- Check-Cap Ltd. (the
"Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ:
CHEKZ), a clinical stage medical diagnostics company engaged in the
development of C-Scan®, an ingestible capsule-based device for
preparation-free colorectal cancer screening, today announced it
will be featured as a presenting company at the 20th
Annual Rodman & Renshaw Global Investment Conference, sponsored
by H.C. Wainwright & Co., LLC. The conference is being
held on September 4-6, 2018 at
the St. Regis New York Hotel in New York
City.
Alex Ovadia, Chief Executive
Officer of Check-Cap, will provide an overview of the Company's
business during the live presentation and will be available to
participate in one-on-one meetings with investors who are
registered to attend the conference.
If you are an institutional investor, and would like to attend
the Company's presentation, please click on the following link
(www.rodmanevents.com ) to register for the conference. Once
your registration is confirmed, you will be prompted to log into
the conference website to request a one-on-one meeting with the
Company.
Event: Check-Cap Presentation
Date: Wednesday, September 5,
2018
Time: 3:00 p.m. EDT
Location: Library, 2nd Floor; St. Regis New
York Hotel
To access a live webcast of this presentation, please visit
http://ir.check-cap.com/events-and-presentations. A replay will be
available for 90 days following the presentation.
About Check-Cap
Check-Cap is a clinical-stage medical diagnostics company
developing C-Scan®, an ingestible capsule-based device for
preparation-free colorectal cancer screening.
Utilizing innovative ultra-low dose X-ray and wireless
communication technologies, the capsule generates information on
the contours of the inside of the colon as it passes naturally.
This information is used to create a 3D map of the colon, which
allows physicians to look for polyps and other abnormalities.
Designed to improve the patient experience and increase the
willingness of individuals to participate in recommended colorectal
cancer screening, C-Scan removes many frequently-cited barriers,
such as laxative bowel preparation, invasiveness and sedation.
Legal Notice Regarding Forward-Looking Statements
This press release contains "forward-looking statements." Words
such as "may," "should," "could," "would," "predicts," "potential,"
"continue," "expects," "anticipates," "future," "intends," "plans,"
"believes," "estimates," and similar expressions, as well as
statements in future tense, often signify forward-looking
statements. Forward-looking statements should not be read as a
guarantee of future performance or results and may not be accurate
indications of when such performance or results will be achieved.
Forward-looking statements are based on information that the
Company has when those statements are made or management's good
faith belief as of that time with respect to future events, and are
subject to risks and uncertainties that could cause actual
performance or results to differ materially from those expressed in
or suggested by the forward-looking statements. For a discussion of
these and other risks that could cause such differences and that
may affect the realization of forward-looking statements, please
refer to "Forward-looking Statements" and "Risk Factors" in the
Company's Annual Report on Form 20-F for its fiscal year ended
December 31, 2017 and other filings
with the Securities and Exchange Commission (SEC). Investors and
security holders are urged to read these documents free of charge
on the SEC's web site at http://www.sec.gov. The Company assumes no
obligation to publicly update or revise its forward-looking
statements as a result of new information, future events or
otherwise.
Investor Contacts
Vivian
Cervantes
PCG Advisory
+1-646-863-6274
vivian@pcgadvisory.com
Meirav Gomeh-Bauer
+972-54-4764979
Meirav@bauerg.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/check-cap-announces-participation-at-the-20th-annual-rodman--renshaw-global-investment-conference-300703986.html
SOURCE Check-Cap Ltd.